The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular determinants of response and resistance to anti-PD-(L)1 blockade in patients with NSCLC profiled with targeted next-generation sequencing (NGS).
 
Matthew David Hellmann
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech; Janssen; Merck; Novartis
Research Funding - Bristol-Myers Squibb; Genentech/Roche
 
Francisco Sanchez-Vega
No Relationships to Disclose
 
Konnor La
No Relationships to Disclose
 
Hira Rizvi
No Relationships to Disclose
 
Darragh Halpenny
No Relationships to Disclose
 
Andrew Plodkowski
No Relationships to Disclose
 
Niamh Long
No Relationships to Disclose
 
Walid Chatila
No Relationships to Disclose
 
Philip Jonsson
No Relationships to Disclose
 
Kathryn Cecilia Arbour
No Relationships to Disclose
 
Jamie E. Chaft
Honoraria - Dava Oncology
Consulting or Advisory Role - AstraZeneca/MedImmune; Clovis Oncology; Genentech/Roche
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; AVEO; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck; Novartis
Research Funding - Biomarin
 
Mark G. Kris
Consulting or Advisory Role - ARIAD; AstraZeneca; Genentech/Roche
Research Funding - Genentech/Roche (Inst); Puma Biotechnology (Inst)
 
Michael F. Berger
Consulting or Advisory Role - Cancer Genetics; Sequenom
 
Barry S. Taylor
No Relationships to Disclose
 
Ahmet Zehir
No Relationships to Disclose
 
Maria E. Arcila
No Relationships to Disclose
 
Marc Ladanyi
Honoraria - Merck (I)
Consulting or Advisory Role - NCCN/AstraZeneca; NCCN/Boehringer Ingelheim
Research Funding - Loxo (Inst)
 
Gregory J. Riely
Consulting or Advisory Role - Genentech; Novartis; Novartis; Roche
Research Funding - ARIAD (Inst); GlaxoSmithKline (Inst); Infinity Pharmaceuticals (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Novartis
 
Nikolaus Schultz
No Relationships to Disclose